CD19-targeted CAR T Cells for Relapsed or Refractory (R/R) Large B-cell Lymphoma

NCT06479356 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Hodgkin Lymphoma
Large B-cell Lymphoma

Interventions

BIOLOGICAL: Relma-cel

Sponsor

Shanghai Ming Ju Biotechnology Co., Ltd.